VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$1.07
+0.01 (+0.94%)
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +2,575.7% upside
Low Target $25.08
Average Target $28.63
High Target $44.18
Current Price $1.07
Current
$1.07
Target
$28.63
$25.08 $28.63 avg $44.18
Scenario Analysis
Bear Case
$25.08
2,243.9%
Low target
Base Case
$28.63
+2,575.7%
Avg target
Bull Case
$44.18
+4,029.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$5.30
-79.8% from high
52-Week Low
$1.07
+0.0% from low
Target vs 52W High
$28.63
+440.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.6%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -38.5%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.0%